aid: abinitio-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/abinitio-bio.png
name: Abinitio Bio
description: >-
  Abinitio Bio builds AI foundation models for biopharmaceutical manufacturing,
  positioning itself as the intelligence layer for drug manufacturing. Its first
  model, Echo, predicts manufacturing outcomes to assess manufacturability from
  day one through process scale-up — evaluating molecules early to reduce
  aggregation and regulatory liabilities, recommending optimal cell lines, media
  formulations, and bioprocess parameters, predicting process behavior across
  scales and operating conditions, and delivering lab-validated candidate
  molecules, processes, and characterization data ready for commercial scale-up.
  Founded in 2026 in Boston and backed by Y Combinator (Spring 2026), MIT's
  Researcher-to-Entrepreneur Accelerator, and Fifty Years' 5050 Program. The
  company operates a B2B model with pharmaceutical companies and CDMOs and does
  not currently publish a public API or developer platform.
url: https://raw.githubusercontent.com/api-evangelist/abinitio-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- y-combinator
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Artificial Intelligence
- Drug Manufacturing
- Machine Learning
- Pharmaceuticals
- Foundation Models
apis: []
common:
- type: DomainSecurity
  url: security/abinitio-bio-domain-security.yml
- type: Website
  url: https://www.abinitio-bio.com
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence